Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v4-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2017-07-27 | 2017-07-19 |
| Drug Identification Number | 02182777 | 02182777 |
| Brand name | METHOTREXATE INJECTION USP | METHOTREXATE INJECTION USP |
| Common or Proper name | METHOTREXATE | METHOTREXATE |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | METHOTREXATE | METHOTREXATE |
| Strength(s) | 25MG | 25MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS | INTRA-ARTERIAL INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 5x2mL VIAL/AMPOULE | VIAL/AMPOULE |
| ATC code | L01BA | L01BA |
| ATC description | ANTIMETABOLITES | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2017-07-10 | 2017-07-10 |
| Estimated end date | 2017-10-16 | 2017-10-09 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product under allocation. Please note that the following formats are currently available: DIN Product name Product Description Package size 2182777 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL, Multidose Vial ONCO-TAINTM vial, 1 x 20 mL 2182955 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL vial, 5 x 2 mL 2182971 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL ONCO-TAINTM vial, 1 x 20 mL 2422166 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.3 mL 2422174 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.4 mL 2422182 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.6 mL 2422190 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.8 mL 2422204 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 1 mL | Product under allocation. Please note that the following formats are currently available: DIN Product name Product Description Package size 2182777 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL, Multidose Vial ONCO-TAINTM vial, 1 x 20 mL 2182955 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL vial, 5 x 2 mL 2182971 METHOTREXATE INJECTION USP Solution for Injection Single-use, 25 mg/mL ONCO-TAINTM vial, 1 x 20 mL 2422166 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.3 mL 2422174 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.4 mL 2422182 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.6 mL 2422190 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 0.8 mL 2422204 METHOTREXATE INJECTION USP Solution for Injection, 25 mg/mL *Syringe, 1 x 1 mL |
| Health Canada comments |